152 related articles for article (PubMed ID: 20589948)
1. Skin laser treatments enhancing transdermal delivery of ALA.
Gómez C; Costela Á; García-Moreno I; Llanes F; Teijón JM; Blanco MD
J Pharm Sci; 2011 Jan; 100(1):223-31. PubMed ID: 20589948
[TBL] [Abstract][Full Text] [Related]
2. Laser treatments on skin enhancing and controlling transdermal delivery of 5-fluorouracil.
Gómez C; Costela A; García-Moreno I; Llanes F; Teijón JM; Blanco D
Lasers Surg Med; 2008 Jan; 40(1):6-12. PubMed ID: 18220260
[TBL] [Abstract][Full Text] [Related]
3. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of topical 5-aminolaevulinic acid delivery by erbium:YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation.
Fang JY; Lee WR; Shen SC; Fang YP; Hu CH
Br J Dermatol; 2004 Jul; 151(1):132-40. PubMed ID: 15270882
[TBL] [Abstract][Full Text] [Related]
5. The influence of topical formulations on the permeation of 5-aminolevulinic acid and its n-butyl ester through excised human stratum corneum.
Winkler A; Müller-Goymann CC
Eur J Pharm Biopharm; 2005 Aug; 60(3):427-37. PubMed ID: 15996584
[TBL] [Abstract][Full Text] [Related]
6. Nonablative fractional laser as a tool to facilitate skin penetration of 5-aminolaevulinic acid with minimal skin disruption: a preliminary study.
Lim HK; Jeong KH; Kim NI; Shin MK
Br J Dermatol; 2014 Jun; 170(6):1336-40. PubMed ID: 24386881
[TBL] [Abstract][Full Text] [Related]
7. Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:YAG laser.
Lee WR; Shen SC; Pai MH; Yang HH; Yuan CY; Fang JY
J Control Release; 2010 Jul; 145(2):124-33. PubMed ID: 20359510
[TBL] [Abstract][Full Text] [Related]
8. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation.
Forster B; Klein A; Szeimies RM; Maisch T
Exp Dermatol; 2010 Sep; 19(9):806-12. PubMed ID: 20636354
[TBL] [Abstract][Full Text] [Related]
9. Erbium-yttrium-aluminum-garnet laser irradiation ameliorates skin permeation and follicular delivery of antialopecia drugs.
Lee WR; Shen SC; Aljuffali IA; Li YC; Fang JY
J Pharm Sci; 2014 Nov; 103(11):3542-3552. PubMed ID: 25187109
[TBL] [Abstract][Full Text] [Related]
10. Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination.
Lee WR; Pan TL; Wang PW; Zhuo RZ; Huang CM; Fang JY
J Control Release; 2008 Jun; 128(3):200-8. PubMed ID: 18471920
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of skin optical clearing efficacy using photo-irradiation.
Liu C; Zhi Z; Tuchin VV; Luo Q; Zhu D
Lasers Surg Med; 2010 Feb; 42(2):132-40. PubMed ID: 20166162
[TBL] [Abstract][Full Text] [Related]
12. Erbium:YAG laser-mediated oligonucleotide and DNA delivery via the skin: an animal study.
Lee WR; Shen SC; Liu CR; Fang CL; Hu CH; Fang JY
J Control Release; 2006 Oct; 115(3):344-53. PubMed ID: 17005286
[TBL] [Abstract][Full Text] [Related]
13. Skin Pretreatment With Conventional Non-Fractional Ablative Lasers Promote the Transdermal Delivery of Tranexamic Acid.
Hsiao CY; Sung HC; Hu S; Huang CH
Dermatol Surg; 2016 Jul; 42(7):867-74. PubMed ID: 27286416
[TBL] [Abstract][Full Text] [Related]
14. Skin pretreatment with lasers promotes the transdermal delivery of vitamin C derivatives.
Hsiao CY; Huang CH; Hu S; Ko YS; Sung HC; Huang SY
Lasers Med Sci; 2011 May; 26(3):369-76. PubMed ID: 21120566
[TBL] [Abstract][Full Text] [Related]
15. Transdermal drug delivery enhanced and controlled by erbium:YAG laser: a comparative study of lipophilic and hydrophilic drugs.
Lee WR; Shen SC; Lai HH; Hu CH; Fang JY
J Control Release; 2001 Jul; 75(1-2):155-66. PubMed ID: 11451505
[TBL] [Abstract][Full Text] [Related]
16. Skin pretreatment with an Er:YAG laser promotes the transdermal delivery of three narcotic analgesics.
Lee WR; Shen SC; Fang CL; Liu CR; Fang JY
Lasers Med Sci; 2007 Nov; 22(4):271-8. PubMed ID: 17334674
[TBL] [Abstract][Full Text] [Related]
17. The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil.
Lee WR; Shen SC; Wang KH; Hu CH; Fang JY
J Pharm Sci; 2002 Jul; 91(7):1613-26. PubMed ID: 12115823
[TBL] [Abstract][Full Text] [Related]
18. Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy.
McLoone N; Donnelly RF; Walsh M; Dolan OM; McLoone S; McKenna K; McCarron PA
Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):183-90. PubMed ID: 18717959
[TBL] [Abstract][Full Text] [Related]
19. Q-switched 1064-nm dymium-doped yttrium aluminum garnet laser irradiation induces skin collagen synthesis by stimulating MAPKs pathway.
Yang Z; Xiang H; Duan X; Liu J; He X; He Y; Hu S; He L
Lasers Med Sci; 2019 Jul; 34(5):963-971. PubMed ID: 30448939
[TBL] [Abstract][Full Text] [Related]
20. Laser assisted drug delivery: a review of an evolving technology.
Sklar LR; Burnett CT; Waibel JS; Moy RL; Ozog DM
Lasers Surg Med; 2014 Apr; 46(4):249-62. PubMed ID: 24664987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
